Japan

Exploring Diversity with Single-Cell Clarity

Confidently scale your cell atlas or lineage study with the new C1 medium-cell HT IFC

特集

The C1 mRNA Seq HT IFC advantage

  • Improve efficiency by loading two samples per IFC.
  • Identify thousands of genes per cell.
  • Deepen your understanding of cell function and behavior by using C1 with on-IFC imaging to correlate cell phenotype to expression profile.

As single-cell research expands around the globe, researchers are profiling greater numbers of cells to identify new cellular subtypes. Scientists can then explore the role and function of each cell population in health and disease states by characterizing their genotypic, transcriptional, epigenetic and proteomic phenotypes. The C1™ system supports more automated single-cell applications than any other platform, enabling greater understanding of cellular diversity and function across many areas of disease research.

The new C1 Single-Cell mRNA Seq HT IFC is designed to expand current understanding of cellular heterogeneity by empowering scientists studying cancer, stem cells and organismal development with better research capabilities, improved single-cell capture and high-efficiency workflow performance. Isolate up to 800 medium size (10–17 µm) single cells for mRNA sequencing analysis.

“The release of the new medium-cell HT IFC with higher single-cell capture performance is exciting. With this new offering on the C1 system, researchers have a powerful new tool to explore the diversity of cell populations at single-cell resolution, discover rare and novel cell types and characterize their role in life.”
—Chris Linthwaite, Fluidigm President and CEO

Improved reagents, better gene detection

Together with the C1 Single-Cell mRNA Seq HT Reagent Kit v2, the medium HT IFC (high throughput integrated fluidic circuit) detects thousands of genes per cell using 3′ end counting and delivers excellent sensitivity, with design elements that provide powerful control over experimental costs and data quality. New HT product pricing makes this advanced technology more accessible while enabling larger single-cell studies.

“The release of the new medium-cell HT IFC with higher single-cell capture performance is exciting,” said Fluidigm President and CEO Chris Linthwaite. “With this new offering on the C1 system, researchers have a powerful new tool to explore the diversity of cell populations at single-cell resolution, discover rare and novel cell types and characterize their role in life.”

Clear insights

The new medium-cell HT IFC empowers researchers to discover and characterize critical cell populations that remain virtually invisible in the absence of single-cell resolution. It’s a development that promises to reveal fresh scientific insights into the biological roles of rare cell types.

Learn more about the C1 system and the power of microfluidics with single-cell IFCs.

fluidigm

For Research Use Only. Not for use in diagnostic procedures.